Inspire Medical Systems (INSP) Set to Announce Earnings on Tuesday

Inspire Medical Systems (NYSE:INSP) is set to announce its earnings results after the market closes on Tuesday, May 7th. Analysts expect Inspire Medical Systems to post earnings of ($0.63) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.53. The firm had revenue of $192.51 million for the quarter, compared to analysts’ expectations of $186.75 million. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The company’s revenue for the quarter was up 39.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.10 EPS. On average, analysts expect Inspire Medical Systems to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inspire Medical Systems Stock Performance

NYSE:INSP opened at $249.72 on Friday. The stock’s 50-day simple moving average is $213.36 and its 200 day simple moving average is $189.05. Inspire Medical Systems has a 52-week low of $123.27 and a 52-week high of $330.00. The company has a market cap of $7.57 billion, a P/E ratio of -337.46 and a beta of 1.35.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Morgan Stanley began coverage on shares of Inspire Medical Systems in a research report on Tuesday, March 19th. They set an “overweight” rating and a $250.00 price target on the stock. Jefferies Financial Group started coverage on Inspire Medical Systems in a research note on Friday, January 19th. They issued a “buy” rating and a $245.00 price objective on the stock. Royal Bank of Canada initiated coverage on Inspire Medical Systems in a report on Friday, April 19th. They set an “outperform” rating and a $285.00 target price on the stock. KeyCorp began coverage on Inspire Medical Systems in a report on Tuesday, February 6th. They set an “overweight” rating and a $278.00 price target for the company. Finally, Truist Financial reaffirmed a “buy” rating and set a $280.00 price objective on shares of Inspire Medical Systems in a research report on Wednesday, March 20th. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $272.20.

Insiders Place Their Bets

In related news, insider Randy Ban sold 3,060 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $182.01, for a total value of $556,950.60. Following the completion of the transaction, the insider now owns 3,029 shares of the company’s stock, valued at $551,308.29. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 40,000 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the completion of the transaction, the chief executive officer now owns 63,658 shares of the company’s stock, valued at $13,055,619.22. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Randy Ban sold 3,060 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $182.01, for a total transaction of $556,950.60. Following the completion of the sale, the insider now owns 3,029 shares in the company, valued at $551,308.29. The disclosure for this sale can be found here. Insiders have sold a total of 76,371 shares of company stock worth $15,664,278 in the last quarter. Corporate insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.